מרונם 500 מג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

MEROPENEM AS TRIHYDRATE

MAH:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

ATC_code:

J01DH02

pharmaceutical_form:

אבקה להכנת תמיסה לזריקה

composition:

MEROPENEM AS TRIHYDRATE 500 MG/VIAL

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

ASTRA ZENECA UK LIMITED

therapeutic_group:

MEROPENEM

therapeutic_area:

MEROPENEM

therapeutic_indication:

Meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis. - Septicemia. Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

authorization_date:

2012-01-31